[{"ID":"12720_27_NCT03296930","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nNo, the patient is excluded from the clinical trial because they have a history of inguinal hernia surgery, which is not specified as an exclusion criterion but could potentially be relevant to the study. Additionally, the patient's recent biopsy was negative for hepatocellular carcinoma, which is not an inclusion criterion. Therefore, the patient does not meet the inclusion criteria for the clinical trial.\n\n{%E2%80%8B%20excluded%20\n\nCorrect! The patient is excluded from the clinical trial because they have a history of inguinal hernia surgery, which is not specified as an exclusion criterion but could potentially be relevant to the study. Additionally, the patient's recent biopsy was negative for hepatocellular carcinoma, which is not an inclusion criterion. Therefore, the patient does not meet the inclusion criteria for the clinical trial.\n\n{%E2%80%8B%20not%20relevant%20\n\nIncorrect. The patient's history of inguinal hernia surgery is not an exclusion criterion for the clinical trial, and their recent biopsy being negative for hepatocellular carcinoma does not affect their eligibility for the study. Therefore, the patient is eligible for the clinical trial.","PROBA":0.9899756231},{"ID":"30672_65_NCT01883024","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient note and the clinical trial information provided, the patient is excluded from the clinical trial because they have been diagnosed with cardiomyopathy, which is listed as an exclusion criterion. Therefore, the answer is (B) excluded.","PROBA":0.9519048705},{"ID":"12418_27_NCT00720434","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. Excluded","PROBA":0.9660707414},{"ID":"17032_36_NCT01491828","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient note, the patient is not eligible for the clinical trial because she has a known medical condition (PCO) that is not listed as an exclusion criterion, but it may affect the study results. Therefore, option B: excluded is the best answer.","PROBA":0.9786684183},{"ID":"7100_15_NCT04821219","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note and the clinical trial's inclusion and exclusion criteria, the patient is not eligible for the clinical trial. The patient has a history of coronary artery disease, which is an exclusion criterion for the trial. Additionally, the patient has a recent history of diverticulitis, which may be an exclusion criterion as well.","PROBA":0.9900681973},{"ID":"8090_17_NCT04210791","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. excluded","PROBA":0.9474215508},{"ID":"7091_15_NCT04730765","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible\n\nThe patient is eligible for the clinical trial because they meet the inclusion criteria of having a history of CAD and being diagnosed with pancreatic adenocarcinoma, and they do not meet any of the exclusion criteria listed.","PROBA":0.9862520623},{"ID":"10176_15_NCT02081625","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20B%3A%20excluded%20\n\nThe patient is excluded from the clinical trial because they have a history of a family member with a similar condition (Duchenne muscular dystrophy) and have participated in other pharmacological clinical trial that might recover dystrophin protein by the readthrough or the exon-skipping therapy. This is in violation of exclusion criterion 1.","PROBA":0.9865940544},{"ID":"12547_27_NCT01750515","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.9668300509},{"ID":"8073_17_NCT03984721","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient note and the clinical trial information, the patient is excluded from the clinical trial. The exclusion criteria state that the patient must have sufficient tissue material to perform the new technique, and the patient note mentions that the patient has systemic amyloidosis (involvement of lungs, tongue, bladder, heart), which may not provide sufficient tissue material for the new technique. Therefore, option B: excluded is the correct answer.","PROBA":0.9868049346},{"ID":"12485_27_NCT01292161","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. excluded","PROBA":0.9608898237},{"ID":"7792_17_NCT00961467","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9837724045},{"ID":"25398_36_NCT03086018","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient note and the clinical trial information provided, the patient is not eligible for the clinical trial. The patient has sensorineural hearing loss in the left ear, which is an active ear disease and is listed as an exclusion criterion for the clinical trial. Therefore, option B (excluded) is the correct answer.","PROBA":0.9853872481},{"ID":"7690_17_NCT00153933","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient note and the clinical trial information provided, the patient is excluded from participating in the clinical trial. This is because the patient has renal insufficiency (serum creatinine levels > 2mg\/dL) which is listed as an exclusion criterion for the trial. Therefore, the correct answer is (B) excluded.","PROBA":0.9845499778},{"ID":"14123_30_NCT02758977","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible\n\n# B: excluded\n\n# C: not relevant for clinical trial","PROBA":0.9735244455},{"ID":"11608_17_NCT01695369","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B eligible%E2%80%8B","PROBA":0.9833507267},{"ID":"30849_65_NCT03362762","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note and the clinical trial's inclusion and exclusion criteria, the patient is not eligible for the clinical trial. The patient has type 1 diabetes, which is not included in the clinical trial's inclusion criteria, which only specify type 2 diabetes. Additionally, the patient's age (25 years old) is not within the specified age range of 45-74 years old for the clinical trial. Therefore, option B (excluded) is the correct answer.","PROBA":0.9955630913},{"ID":"5559_12_NCT04731493","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA. Eligible","PROBA":0.9760134816},{"ID":"30801_65_NCT02782195","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20B: excluded%20-%20experienced%20recurrent%20severe%20hypoglycemic%20unawareness)%20","PROBA":0.9900615686},{"ID":"6986_15_NCT03858192","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA: eligible","PROBA":0.9015228881},{"ID":"7703_17_NCT00256776","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note and the clinical trial's inclusion and exclusion criteria, the patient is excluded from the clinical trial. The patient has systemic amyloidosis, which is listed as an exclusion criterion for the study. Additionally, the patient's creatinine clearance is <30 mL\/minute, which is also an exclusion criterion.","PROBA":0.9747212994},{"ID":"19031_27_NCT04148222","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nA: eligible","PROBA":0.8916225334},{"ID":"7701_17_NCT00240162","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9971006736},{"ID":"25463_36_NCT03600324","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20B:excluded%20C:not%20relevant%20for%20clinical%20trial.","PROBA":0.9721877934},{"ID":"14162_30_NCT03296878","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient note, the patient is a 33-year-old woman who has been diagnosed with Hashimoto's thyroiditis and is currently taking Levothyroxine. She has a high anti-TPO level and a normal TSH level. She is overweight with a BMI of 31. She has a family history of the disease.\n\nThe clinical trial is focused on the impact of food prices on grocery shopping choices for mothers. The exclusion criteria for the trial are male, < 18 years of age, not the primary grocery shopper for their household, health conditions or food practices that substantially limit food choice, and currently pregnant.\n\nBased on the patient note, the patient is not eligible for the clinical trial because she is not a mother and does not have children living in her household. Therefore, the correct answer is B: excluded.","PROBA":0.9771600195},{"ID":"6964_15_NCT03578445","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible\n#B: excluded\n#C: not relevant for clinical trial","PROBA":0.943439994},{"ID":"10316_15_NCT03433807","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient note and the clinical trial information provided, the patient is eligible for the clinical trial. The patient has been diagnosed with Duchenne Muscular Dystrophy (DMD), which is the indication for the clinical trial. The patient's age and medical condition, as described in the patient note, meet the inclusion criteria for the clinical trial. Specifically, the patient's diagnosis of DMD and the absence of dystrophin protein in the muscle biopsy satisfy the inclusion criteria for the clinical trial. None of the exclusion criteria listed in the clinical trial are mentioned in the patient note, so the patient is eligible for the clinical trial. Therefore, the correct answer is (A) eligible.","PROBA":0.9929186647},{"ID":"16862_36_NCT00105066","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nThe patient is eligible for the clinical trial because she does not have any of the exclusion criteria listed, such as diabetes, high blood pressure, recent weight loss, or a history of hepatitis or kidney disease. Additionally, she is within the age range of 18-70 years old, which is the inclusion criteria for the study.","PROBA":0.9817827761},{"ID":"27576_40_NCT00970658","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB. Excluded","PROBA":0.9860293865},{"ID":"10221_15_NCT02398786","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is eligible for the clinical trial. The patient has been diagnosed with DMD, which meets the inclusion criterion of the clinical trial, which is \"diagnosed with DM.\" None of the exclusion criteria, such as \"not diagnosed with DM\" or \"unaffected family members,\" are met. Therefore, the patient is eligible for the clinical trial. The correct answer is (A) eligible.","PROBA":0.9850134537},{"ID":"12509_27_NCT01498068","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.8839573503},{"ID":"21420_30_NCT04397484","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient note and the clinical trial information provided, the patient is excluded from the clinical trial. The exclusion criteria listed in the clinical trial are:\n\n* patient refusal\n* ASA physical status > III\n* pregnancy\n* neuromuscular disorder\n* prior surgery in the popliteal fossa\n* coagulopathy\n* allergy to local anaesthetic drugs\n* skin infection at the site of needle insertion\n\nThe patient note mentions that the patient has a history of osteoarthritis and is currently using nonsteroidal anti-inflammatory drugs (NSAIDs), which would be considered a prior surgery in the popliteal fossa and would make the patient ineligible for the clinical trial. Therefore, the correct answer is (B) excluded.","PROBA":0.9784435382},{"ID":"12359_27_NCT00164073","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. Excluded","PROBA":0.8725887537},{"ID":"7078_15_NCT04604730","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient is excluded from the clinical trial because they have a history of coronary artery disease, which is listed as an exclusion criterion. Therefore, the answer is (B) excluded.","PROBA":0.9789003214},{"ID":"17158_36_NCT02556749","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's information and the inclusion and exclusion criteria of the clinical trial, the patient is not eligible for the study. This is because the patient has a history of PCO, which is an exclusion criterion for the study. Additionally, the patient is currently taking no medication for her PCO, which may be a contraindication for the study.","PROBA":0.966879802},{"ID":"25316_36_NCT02467244","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient's note and the inclusion criteria of the clinical trial, the patient is eligible for the clinical trial. The patient has hypothyroidism, which is one of the inclusion criteria for the study. Additionally, the patient is not taking any other medications and does not have any other comorbidities that would exclude her from the study. Therefore, option A is the correct response.","PROBA":0.9727855619},{"ID":"11768_17_NCT02793232","TOPIC_YEAR":2022,"RESPONSE":"$}}%A%>","PROBA":0.7445548512},{"ID":"14125_30_NCT02789163","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient is eligible for the clinical trial. The patient is a woman over the age of 18, and the patient has a scheduled diagnostic ultrasound examination. The patient does not have any breast abnormalities greater than one quadrant, which is an exclusion criterion for the clinical trial. Therefore, option A (eligible) is the correct response.","PROBA":0.9901110633},{"ID":"17322_36_NCT03802734","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9852171466},{"ID":"5533_12_NCT04382612","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient note and the clinical trial information provided, the patient is eligible for the clinical trial. The patient has severe mitral regurgitation due to posterior leaflet prolapse, which is the primary inclusion criterion for the trial. Additionally, the patient has a history of gestational diabetes mellitus, hypertension during pregnancy, and obesity, which are not exclusion criteria for the trial. Therefore, option A (eligible) is the correct response.","PROBA":0.9954998235},{"ID":"10050_15_NCT00830583","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20B%20excluded%20\n\nThe patient is excluded from the clinical trial because they have a confirmed and documented diagnosis of an etiologic muscular disease (Duchenne Muscular Dystrophy) determined by the histological analysis of muscle biopsy. This is one of the exclusion criteria for the clinical trial.","PROBA":0.9773231895},{"ID":"5530_12_NCT04343313","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9260940403},{"ID":"10317_15_NCT03439670","TOPIC_YEAR":2022,"RESPONSE":"#A: eligible","PROBA":0.9947289005},{"ID":"30427_65_NCT00283218","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, the patient is excluded from the trial. The patient has a history of cardiomyopathy, which is listed as an exclusion criterion. Additionally, the patient is currently taking medications for cardiomyopathy, which would make them ineligible for the trial.","PROBA":0.9908134986},{"ID":"25356_36_NCT02733549","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, the patient is not eligible for the study. The patient's history of hypothyroidism and low vitamin D level may be considered as chronic diseases that could affect liver function tests, which is an exclusion criterion. Additionally, the patient's dizziness may be related to her hearing loss, which is not a symptom of acute liver dysfunction, the primary focus of the clinical trial. Therefore, option B (excluded) is the most appropriate response.","PROBA":0.9834073878},{"ID":"21413_30_NCT04381624","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB","PROBA":0.9749346495},{"ID":"12714_27_NCT03241823","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.9782424688},{"ID":"6561_15_NCT00068575","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, the patient is excluded from the trial. The patient has a history of coronary artery disease, which is listed as an exclusion criterion. Additionally, the patient has a recent history of diverticulitis, which may be considered a significant pulmonary disease, another exclusion criterion. Therefore, the patient does not meet the inclusion criteria and is not eligible for the clinical trial. The correct answer is (B) excluded.","PROBA":0.9881000045},{"ID":"33403_71_NCT00297154","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9809353948},{"ID":"21305_30_NCT03736109","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient note and the clinical trial information provided, the patient is eligible for the clinical trial. The patient has osteoarthritis, which is one of the inclusion criteria for the trial, and does not meet any of the exclusion criteria. Therefore, option A is the correct answer.","PROBA":0.9749603985}]
